Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives by Giacomo Barchiesi, Michela Roberto, Monica Verrico, Patrizia Vici, Silverio Tomao, Federica Tomao, Federica Tomao

Get full text

High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report by Paola Giancontieri, Camilla Turetta, Giacomo Barchiesi, Angelina Pernazza, Gemma Pignataro, Giuliano D’Onghia, Daniele Santini, Federica Tomao

Get full text

The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets by Michela Roberto, Giulia Arrivi, Mattia Alberto Di Civita, Giacomo Barchiesi, Emanuela Pilozzi, Paolo Marchetti, Daniele Santini, Federica Mazzuca, Silverio Tomao

Get full text

Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis by Michela Roberto, Giacomo Barchiesi, Blerina Resuli, Monica Verrico, Iolanda Speranza, Leonardo Cristofani, Federica Pediconi, Federica Tomao, Andrea Botticelli, Daniele Santini

Get full text

Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives by Giacomo Barchiesi, Marco Mazzotta, Eriseld Krasniqi, Laura Pizzuti, Daniele Marinelli, Elisabetta Capomolla, Domenico Sergi, Antonella Amodio, Clara Natoli, Teresa Gamucci, Enrico Vizza, Paolo Marchetti, Claudio Botti, Giuseppe Sanguineti, Gennaro Ciliberto, Maddalena Barba, Patrizia Vici

Get full text

Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS... by Laura Pizzuti, Eriseld Krasniqi, Chiara Mandoj, Daniele Marinelli, Domenico Sergi, Elisabetta Capomolla, Giancarlo Paoletti, Claudio Botti, Ramy Kayal, Francesca Romana Ferranti, Isabella Sperduti, Letizia Perracchio, Giuseppe Sanguineti, Paolo Marchetti, Gennaro Ciliberto, Giacomo Barchiesi, Marco Mazzotta, Maddalena Barba, Laura Conti, Patrizia Vici

Get full text

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study by Giulia Bon, Laura Pizzuti, Valentina Laquintana, Rossella Loria, Manuela Porru, Caterina Marchiò, Eriseld Krasniqi, Maddalena Barba, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Giacomo Barchiesi, Marco Mazzotta, Daniele Marinelli, Silverio Tomao, Paolo Marchetti, Maria Rosaria Valerio, Rosanna Mirabelli, Antonio Russo, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Francesco Giotta, Carlo Garufi, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Giuseppe Sanguineti, Isabella Sperduti, Anna Sapino, Ruggero De Maria, Carlo Leonetti, Angelo Di Leo, Gennaro Ciliberto, Rita Falcioni, Patrizia Vici

Get full text